"While it's early, if that number held throughout the year, that would make it the lowest median price increase in over a decade," says Ciaccia.
"The list prices for drugs create great signals for what might be happening in the marketplace and what incentives might be driving certain behaviors..." says Ciaccia.
"January is typically a popular time to raise prices on brand name drugs, but companies can raise them throughout the year." says Ciaccia.
Ozempic and Paxlovid saw price hikes of about 3% each, according to 46brooklyn, which uses National Average Drug Acquisition Cost data in its analysis.
Collection
[
|
...
]